Objective Diabetes is associated with an upset of hematological and immunological parameters in humans, however information on the effects of Lycopene is scarce. The aim of the study was to gain information on basic changes in hematological parameters as markers for safety since anemia as a complication in diabetic chemotherapy has been reported.
Results Lycopene had anti-anemic effects and improved on the immune status of diabetic rats and these observations were dose independent. There was a decrease in neutrophil, low neutrophil-lymphocyte ratio and platelet counts and stable albumin, globulin levels.

Figure 1

Figure 2
Loading...
On 02 Dec, 2019
On 30 Nov, 2019
On 29 Nov, 2019
On 29 Nov, 2019
Posted 24 Oct, 2019
On 10 Nov, 2019
Received 04 Nov, 2019
On 18 Oct, 2019
Invitations sent on 18 Oct, 2019
On 18 Oct, 2019
On 17 Oct, 2019
On 17 Oct, 2019
On 02 Dec, 2019
On 30 Nov, 2019
On 29 Nov, 2019
On 29 Nov, 2019
Posted 24 Oct, 2019
On 10 Nov, 2019
Received 04 Nov, 2019
On 18 Oct, 2019
Invitations sent on 18 Oct, 2019
On 18 Oct, 2019
On 17 Oct, 2019
On 17 Oct, 2019
Objective Diabetes is associated with an upset of hematological and immunological parameters in humans, however information on the effects of Lycopene is scarce. The aim of the study was to gain information on basic changes in hematological parameters as markers for safety since anemia as a complication in diabetic chemotherapy has been reported.
Results Lycopene had anti-anemic effects and improved on the immune status of diabetic rats and these observations were dose independent. There was a decrease in neutrophil, low neutrophil-lymphocyte ratio and platelet counts and stable albumin, globulin levels.

Figure 1

Figure 2
Loading...